Literature DB >> 26481025

[Complete hydatidiform mole].

Jean-Jacques Candelier1.   

Abstract

"The battle of the sexes begins in the zygote" W. Reik and J. Walter. Complete hydatidiform mole (CHM) is a pathology of the placenta with androgenetic diploid origin (chromosomes only from paternal origin). Placental villi present an abnormal hyperproliferation and hydropic degeneration associated with the absence of embryo. Three mechanisms can be envisaged at its origin: (1) destruction/expulsion of the female pronucleus at the time of fertilization by one or two spermatozoa, the former being followed by an endoreplication of the male pronucleus (homozygous mole), (2) a triploid zygote (fertilization by two spermatozoa) leading to a haploid and a diploid clones. The diploid clone may produce a normal fetus while the haploid clone, after endoreplication, generates a complete hydatidiform mole, (3) a nutritional defect during the differentiation of the oocytes of the female embryo that will affect the integrity and maturity of her oocytes during her adult life and lead to hydatidiform mole. In countries with a poor medical health care system, moles can be invasive or, in rare cases, lead to gestational choriocarcinomas.
© 2015 médecine/sciences – Inserm.

Entities:  

Mesh:

Year:  2015        PMID: 26481025     DOI: 10.1051/medsci/20153110012

Source DB:  PubMed          Journal:  Med Sci (Paris)        ISSN: 0767-0974            Impact factor:   0.818


  2 in total

1.  Molecular and Immunohistochemical Characteristics of Complete Hydatidiform Moles.

Authors:  K B Kubelka-Sabit; I Prodanova; D Jasar; G Bozinovski; V Filipovski; S Drakulevski; D Plaseska-Karanfilska
Journal:  Balkan J Med Genet       Date:  2017-06-30       Impact factor: 0.519

2.  [Epidemioclinical and ultrasonographic profile of hydatidiform moles in Abidjan].

Authors:  Kouamé N'goran; Kouadio Kouamé Eric; Doukouré Brahima; Sétchéou Alihonou; Konan Anhum Nicaise; Ettien Kouamé Jean-Jacques; N'Goan-Domoua Anne-Marie; Konan Alexis Victorien
Journal:  Pan Afr Med J       Date:  2019-07-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.